Costas Lallas, MD

Articles

Dr. Lallas on Understanding Immunotherapy in GU Malignancies

September 6th 2017

Costas Lallas, MD, professor at Sidney Kimmel Medical College, Thomas Jefferson University Hospital, discusses the importance of understanding novel agents such as immunotherapeutic across disciplines in the treatment of genitourinary malignancies.

Dr. Lallas on the Future of Immunotherapy in Genitourinary Malignancies

Costas Lallas, MD

August 30th 2017

Costas Lallas, MD, professor at Sidney Kimmel Medical College, Thomas Jefferson University Hospital, discusses the future of immunotherapy in patients with genitourinary malignancies.

Dr. Lallas Discusses Multidisciplinary Care for Genitourinary Malignancies

Costas Lallas, MD

August 23rd 2017

Costas Lallas, MD, professor at Sidney Kimmel Medical College, Thomas Jefferson University Hospital, discusses multidisciplinary care for genitourinary malignancies.

Dr. Lallas on Ongoing Trials Investigating Immunotherapy for GU Cancer

Costas Lallas, MD

August 8th 2017

Costas Lallas, MD, professor at Sidney Kimmel Medical College, Thomas Jefferson University Hospital, discusses ongoing trials investigating immunotherapy regimens for patients with genitourinary malignancies.

Dr. Lallas on Challenges With Immunotherapy in Genitourinary Malignancies

Costas Lallas, MD

May 25th 2017

Costas Lallas, MD, professor at Sidney Kimmel Medical College, Thomas Jefferson University Hospital, discusses challenges with immunotherapy in genitourinary (GU) malignancies.

Dr. Lallas on Immunotherapy Combinations in Genitourinary Malignancies

Costas Lallas, MD

May 22nd 2017

Costas Lallas, MD, professor at Sidney Kimmel Medical College, Thomas Jefferson University Hospital, discusses combinations of immunotherapy for genitourinary malignancies.